These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 20003831

  • 21. Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer.
    Avgeris M, Koutalellis G, Fragoulis EG, Scorilas A.
    Clin Biochem; 2008 Oct; 41(14-15):1140-9. PubMed ID: 18586020
    [Abstract] [Full Text] [Related]

  • 22. Transforming growth factor-beta 1 gene polymorphisms and expression in the blood of prostate cancer patients.
    Faria PC, Saba K, Neves AF, Cordeiro ER, Marangoni K, Freitas DG, Goulart LR.
    Cancer Invest; 2007 Dec; 25(8):726-32. PubMed ID: 18058470
    [Abstract] [Full Text] [Related]

  • 23. Molecular PCA3 diagnostics on prostatic fluid.
    van Gils MP, Cornel EB, Hessels D, Peelen WP, Witjes JA, Mulders PF, Rittenhouse HG, Schalken JA.
    Prostate; 2007 Jun 01; 67(8):881-7. PubMed ID: 17440939
    [Abstract] [Full Text] [Related]

  • 24. Gene expression profile in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia.
    Alonso V, Neves AF, Marangoni K, Faria PC, Freschi AP, Capaneli AC, Meola J, Goulart LR.
    Cancer Detect Prev; 2009 Jun 01; 32(4):336-7. PubMed ID: 19026495
    [Abstract] [Full Text] [Related]

  • 25. cDNA microarray analysis with amplified RNA after isolation of intact cellular RNA from neoplastic and non-neoplastic prostate tissue separated by laser microdissections.
    Thelen P, Burfeind P, Grzmil M, Voigt S, Ringert RH, Hemmerlein B.
    Int J Oncol; 2004 May 01; 24(5):1085-92. PubMed ID: 15067329
    [Abstract] [Full Text] [Related]

  • 26. [Expression of nucleostemin in prostate cancer tissues and its clinical significance].
    Liu RL, Xu Y, Zhang ZH, Wang M, Sun JT, Qi SY, Zhang Y, Li SZ.
    Zhonghua Nan Ke Xue; 2008 May 01; 14(5):418-22. PubMed ID: 18572860
    [Abstract] [Full Text] [Related]

  • 27. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma.
    Iacopino F, Angelucci C, Lama G, Zelano G, La Torre G, D'Addessi A, Giovannini C, Bertaccini A, Macaluso MP, Martorana G, Sica G.
    Anticancer Res; 2006 May 01; 26(3A):1849-54. PubMed ID: 16827116
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
    Song J, Aumüller G, Xiao F, Wilhelm B, Albrecht M.
    Prostate; 2004 Mar 01; 58(4):394-405. PubMed ID: 14968440
    [Abstract] [Full Text] [Related]

  • 30. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.
    Hessels D, Klein Gunnewiek JM, van Oort I, Karthaus HF, van Leenders GJ, van Balken B, Kiemeney LA, Witjes JA, Schalken JA.
    Eur Urol; 2003 Jul 01; 44(1):8-15; discussion 15-6. PubMed ID: 12814669
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
    Walton TJ, Li G, McCulloch TA, Seth R, Powe DG, Bishop MC, Rees RC.
    Prostate; 2009 Jun 01; 69(8):810-9. PubMed ID: 19189301
    [Abstract] [Full Text] [Related]

  • 36. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z, Liu J, Li S, Shen W.
    Prostate; 2009 Sep 01; 69(12):1292-302. PubMed ID: 19462463
    [Abstract] [Full Text] [Related]

  • 37. High expression of a new marker PCA-1 in human prostate carcinoma.
    Konishi N, Nakamura M, Ishida E, Shimada K, Mitsui E, Yoshikawa R, Yamamoto H, Tsujikawa K.
    Clin Cancer Res; 2005 Jul 15; 11(14):5090-7. PubMed ID: 16033822
    [Abstract] [Full Text] [Related]

  • 38. Increased incidence of luteinizing hormone-releasing hormone receptor gene messenger RNA expression in hormone-refractory human prostate cancers.
    Straub B, Müller M, Krause H, Schrader M, Goessl C, Heicappell R, Miller K.
    Clin Cancer Res; 2001 Aug 15; 7(8):2340-3. PubMed ID: 11489810
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.
    Steiner GE, Newman ME, Paikl D, Stix U, Memaran-Dagda N, Lee C, Marberger MJ.
    Prostate; 2003 Aug 01; 56(3):171-82. PubMed ID: 12772186
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.